Customize your JAMA Network experience by selecting one or more topics from the list below.
Until now, most people feared a diagnosis with the dreaded “C word”—cancer—owing to its associated physical, emotional, and financial hardships as well as its social stigma. However, the rapid progression of coronavirus disease 2019 (COVID-19) from a local issue to a global pandemic has quickly made it a competitor for the spot of the most feared disease, and rightly so, given the intense strain it is placing on us individually and as a society at every level. For me, having been diagnosed with both diseases 4 years apart, COVID-19 has brought back memories of being confronted with my own mortality.
Some conservative estimates suggest that if 30% of the population contracts the disease and it has a 0.5% fatality rate in the US, COVID-19 would trail only heart disease and cancer as major causes of death in the country.1 In the US, more than 16 million people currently have or have survived cancer (about 5% of the population).2 Therefore, it is inevitable that many of them will be affected by COVID-19. Published data show that patients with cancer are more likely to develop the disease, have severe symptoms, and die than the rest of the population.3,4 These data aside, patients with cancer are generally more susceptible to infections, which has led to grave concern among oncologists and patients with cancer alike about what protective measures might be taken.
I was diagnosed with Hodgkin lymphoma during my oncology fellowship training. What I had been treating a few patients for unexpectedly became my fate, too. Facing the uncertainty of a cancer diagnosis was one of the hardest times I have ever experienced personally and professionally. Being an oncologist myself, I understood the prognosis was good, with a 5-year survival rate of 94%. But while these statistics seemed reassuring to me from an oncologist’s perspective, they were not as comforting as a patient. During that time, while I received chemotherapy, I retreated and socially distanced myself to be able to come to terms with the diagnosis emotionally. Most of my close friends did not know what I was going through because I could not handle a well-intentioned but constant barrage of inquiries about my health. I planned everything meticulously; for example, I got a short haircut and then got a wig that looked like my hairstyle, so nothing would look different when I lost my own hair. I continued to see patients once a week and do research from home on other days. I was fortunate to have the best possible outcome thanks to the excellent care I received. Since then, I have recovered well and been in complete remission. And now my life has come full circle from being a patient at Memorial Sloan Kettering Cancer Center to being a faculty member there.
As COVID-19 started spreading in New York, staff at Memorial Sloan Kettering Cancer Center started working from home, moving toward telemedicine and phone visits, and rescheduling nonurgent visits. We also worked on isolating and distancing ourselves socially. However, despite this, a couple of weeks later, on a Monday in March, I tested positive for COVID-19 after having developed the symptoms of fever and body aches the day before. Given my cancer history, I could not help but wonder if my immune system had returned to its baseline and if I would be able to weather this infection without serious complications. The apprehension of what the week might bring was unnerving and scary—would I start finding it difficult to breathe? Would I need to be admitted to the hospital? Would I need to go to the intensive care unit? Would the prior chemotherapy affect my current outcomes?
I tried to work, but my head hurt. I wanted to sleep, but every little sound was amplified in my mind and kept me up. My body ached from the inside out. My fingers were cold, the pulse oximeter reading 88%. My heart rate and anxiety level went up. I rubbed my hands together to improve my circulation. Try again. This time it was 99%. Phew; I could relax until it was time to check it again.
With each passing day my anxiety dropped incrementally as my oxygen saturation remained at 99%. Although the odds were in my favor with this disease currently demonstrating greater than 99% chance of survival, I did not know going into it that I would end up on the right side of these statistics.
As an oncologist and a cancer survivor, I also worried about the patients for whom I was caring. Asking the average person to stay at home and put their life on pause for a few weeks to months can sound like a reasonable measure to take to curb this pandemic. But that is not an option for many patients with cancer receiving active life-saving therapy. So these patients must go to war every day with both cancer and COVID-19—and every patient’s trip to the chemotherapy suite to extend their life has the potential to abruptly shorten it.
As I write this, I have almost recovered from my symptoms, which were fortunately mild. My mouth feels strange and I cannot smell or taste anything. COVID-19 has this unusual complication, much like chemotherapy. No food tastes how it is supposed to, and it takes me down a memory lane I do not really miss or care to go down.
The COVID-19 pandemic, although tragic and destructive, has brought the world together in many ways and made us all part of a bigger community where differences seem insignificant and we have a deeper appreciation of others. As oncologists, we are doing our best to protect our small cancer community from COVID-19 such that one demographic intersects the other minimally or, ideally, not at all. It is wonderful to see oncologists come together to build a registry on these patients with an intent to rapidly share these data to help guide management.5-9
When I had cancer, I felt very supported by and connected with family and loved ones, but I also felt very isolated at the same time. It felt like I was the only one with that “C word” diagnosis, alone on that journey, and they were helpless bystanders, given that I had chosen to distance myself from extended friends and family. This time, with COVID-19, although I needed to physically distance myself and have minimal human contact, I somehow did not feel as alone or socially disconnected knowing that we, as a society, country, and world, are united in our fight against this disease. Although my family and friends live all over the world, we are all dealing with the same issues of life being at a standstill due to COVID-19. May we emerge on the other side with minimal damage from the combined effect of both the “C words.”
Corresponding Author: Urvi A. Shah, MD, Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 530 East 74th Street, New York, NY, 10021 (firstname.lastname@example.org).
Published Online: May 7, 2020. doi:10.1001/jamaoncol.2020.1848
Conflict of Interest Disclosures: Dr Shah reported grants from Celgene and the Parker Institute of Cancer Immunotherapy and personal fees from the Physicians Education Resource.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Shah UA. Cancer and Coronavirus Disease 2019 (COVID-19)—Facing the “C Words”. JAMA Oncol. 2020;6(9):1330–1331. doi:10.1001/jamaoncol.2020.1848
Create a personal account or sign in to: